- Home
- RPRX vs TAP Comparison
RPRX vs TAP Comparison
Compare RPRX & TAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPRX
- TAP
- Stock Information
- Founded
- RPRX 1996
- TAP 1873
- Country
- RPRX United States
- TAP United States
- Employees
- RPRX 89
- TAP N/A
- Industry
- RPRX Biotechnology: Pharmaceutical Preparations
- TAP Beverages (Production/Distribution)
- Sector
- RPRX Health Care
- TAP Consumer Staples
- Exchange
- RPRX Nasdaq
- TAP Nasdaq
- Market Cap
- RPRX 13.6B
- TAP 12.6B
- IPO Year
- RPRX 2020
- TAP N/A
- Fundamental
- Price
- RPRX $30.93
- TAP $55.14
- Analyst Decision
- RPRX Strong Buy
- TAP Hold
- Analyst Count
- RPRX 6
- TAP 14
- Target Price
- RPRX $41.67
- TAP $61.79
- AVG Volume (30 Days)
- RPRX 3.4M
- TAP 1.7M
- Earning Date
- RPRX 02-13-2025
- TAP 02-13-2025
- Dividend Yield
- RPRX 2.74%
- TAP 3.25%
- EPS Growth
- RPRX 518.56
- TAP 275.92
- EPS
- RPRX 2.55
- TAP 4.42
- Revenue
- RPRX $2,266,003,000.00
- TAP $11,682,200,000.00
- Revenue This Year
- RPRX $14.54
- TAP $0.08
- Revenue Next Year
- RPRX $10.94
- TAP N/A
- P/E Ratio
- RPRX $11.99
- TAP $12.23
- Revenue Growth
- RPRX N/A
- TAP 1.23
- 52 Week Low
- RPRX $24.05
- TAP $49.19
- 52 Week High
- RPRX $31.66
- TAP $69.18
- Technical
- Relative Strength Index (RSI)
- RPRX 75.82
- TAP 42.55
- Support Level
- RPRX $29.73
- TAP $53.87
- Resistance Level
- RPRX $31.09
- TAP $55.80
- Average True Range (ATR)
- RPRX 0.73
- TAP 1.31
- MACD
- RPRX 0.28
- TAP 0.09
- Stochastic Oscillator
- RPRX 93.94
- TAP 62.34
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About TAP Molson Coors Beverage Company Class B
Molson Coors owns well-known beer brands including Miller, Coors, Blue Moon, and Carling and ranks as the second-largest beer maker in both value and volume terms in the us, Canada, and the United Kingdom. Through licensing agreements, the firm also brews and distributes beer and hard seltzer under partner brands from Heineken, Anheuser-Busch InBev, Asahi, and Coca-Cola. The brewer uses independent distributors in the us, given the three-tier distribution requirements, while using a combination of distributors and an in-house sales team in Canada and Europe. North America remains its largest market, contributing over 80% of total revenue.